facebook
Subscribe50$/product give away!


Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

ADIPEX-P- phentermine hydrochloride tabletADIPEX-P- phentermine hydrochloride capsule


  1. Patient Information
  2. Patients Must Be Informed About The Risks Of Use Of Phentermine (including The Risks Discussed In Warnings And Precautions), About The Symptoms Of Potential Adverse Reactions And When To Contact A Physician And/or Take Other Action. The Risks Include, But Are Not Limited To:
  3. Manufactured In Croatia By:
  4. Manufactured For:

Patient Information 

Patients must be informed that ADIPEX-Pis ashort-term(a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity, and that coadministration of phentermine with other drugs for weight loss is not recommended [see Indications and Usage (1) and Warnings and Precautions (5)].

Patients must be instructed on how much ADIPEX-Pto take, and when and how to take it [see Dosage and Administration (2)].

Advise pregnant women and nursing mothers not to use ADIPEX-P[see Use in Specific Populations (8.1,8.3)].

Patients Must Be Informed About The Risks Of Use Of Phentermine (including The Risks Discussed In Warnings And Precautions), About The Symptoms Of Potential Adverse Reactions And When To Contact A Physician And/or Take Other Action. The Risks Include, But Are Not Limited To: 

  • Development of primary pulmonary hypertension [see Warnings and Precautions (5.2)]
  • Development of serious valvular heart disease [see Warnings and Precautions (5.3)]
  • Effects on the ability to engage in potentially hazardous tasks [see Warnings and Precautions (5.5)]
  • The risk of an increase in blood pressure [see Warnings and Precautions (5.8) and Adverse Reactions (6)]
  • The risk of interactions [see Contraindications (4), Warnings and Precautions (5) and Drug Interactions (7)]

See also, for example,Adverse Reactions (6)andUse in Specific Populations (8).

The patients must also be informed about

  • the potential for developing tolerance and actions if they suspect development of tolerance [see Warnings and Precautions (5.4)] and
  • the risk of dependence and the potential consequences of abuse [see Warnings and Precautions (5.6), Drug Abuse and Dependence (9), and Overdosage (10)].

Tell patients to keep ADIPEX-Pin a safe place to prevent theft, accidental overdose, misuse or abuse. Selling or giving away ADIPEX-Pmay harm others and is against the law.

All trademarks are the property of their respective owners.

Manufactured In Croatia By: 

Pliva Hrvatska d.o.o.

Zagreb, Croatia

Manufactured For: 

Teva Select Brands, Horsham, PA 19044

Division of Teva Pharmaceuticals USA, Inc.

Rev. Z 3/2017



Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources
2017 © Copyright PharmacyHQ.com. Questions?
Please contact: pharmacyhq.mail@gmail.com